These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7823600)

  • 1. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
    Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
    J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid.
    Beenken SW; Sellers MT; Huang P; Peters G; Krontiras H; Dixon P; Stockard C; Listinsky C; Grizzle WE
    Head Neck; 1999 Sep; 21(6):566-73. PubMed ID: 10449674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.
    Zeng Q; Smith DC; Suscovich TJ; Gooding WE; Trump DL; Grandis JR
    Clin Cancer Res; 2000 Jun; 6(6):2245-51. PubMed ID: 10873074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
    Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-alpha: a surrogate endpoint biomarker?
    Beenken SW; Hockett R; Grizzle W; Weiss HL; Pickens A; Perloff M; Malone WF; Bland KI
    J Am Coll Surg; 2002 Aug; 195(2):149-58. PubMed ID: 12168960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
    Rubin Grandis J; Tweardy DJ; Melhem MF
    Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias.
    Prado SM; Cedrún JL; Rey RL; Villaamil VM; García AA; Ayerbes MV; Aparicio LA
    Exp Mol Pathol; 2010 Oct; 89(2):197-203. PubMed ID: 20599939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting cancer development in oral leukoplakia: ten years of translational research.
    Lee JJ; Hong WK; Hittelman WN; Mao L; Lotan R; Shin DM; Benner SE; Xu XC; Lee JS; Papadimitrakopoulou VM; Geyer C; Perez C; Martin JW; El-Naggar AK; Lippman SM
    Clin Cancer Res; 2000 May; 6(5):1702-10. PubMed ID: 10815888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
    Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
    Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
    Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer.
    Issing WJ; Liebich C; Wustrow TP; Ullrich A
    Anticancer Res; 1996; 16(1):283-8. PubMed ID: 8615622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
    Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
    Grandis JR; Tweardy DJ
    Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
    Benner SE; Wargovich MJ; Lippman SM; Fisher R; Velasco M; Winn RJ; Hong WK
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):73-6. PubMed ID: 8118389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.